RNA vs EVMN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

RNA

37.1
AI Score
VS
EVMN Wins

EVMN

40.1
AI Score

Investment Advisor Scores

RNA

37score
Recommendation
EXTENDED

EVMN

40score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric RNA EVMN Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 1148.3% 0.0% RNA
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 37.1/100 40.1/100 EVMN
Profit Margin -160.0% 0.0% EVMN
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED HOLD Tie

Relative Price Performance (Last 90 Days)

RNA 1M: +10.8% · 3M: +1.2% EVMN 1M: +23.9% · 3M: -40.5%

Current Technical Phase

RNA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 61

RSI (14): 60.7 · Price: $13.20

EVMN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 51.2 · Price: $14.02

Fundamentals Snapshot

Metric RNA EVMN
Market Cap
Forward P/E -2.1 -4.2
Trailing P/E
Revenue (TTM)
Revenue Growth 11.5% 0.0%
Gross Margin -0.3% 1.0%
Operating Margin -0.9% -10.2%
EPS -4.98 -10.69
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, EVMN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.